SCHEMBL14907016

SCHEMBL14907016

COc1c(Cl)cc(Cl)cc1/C=N/NC(=O)c1cc(O)c(O)c(O)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.53
KMT2A Q03164 5/20 0.53
KDM4E B2RXH2 5/20 0.53
NPC1 O15118 3/20 0.53
L3MBTL1 Q9Y468 2/20 0.53
USP2 O75604 1/20 0.53
MCOLN3 Q8TDD5 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
GCGR P47871 3/20 0.50
PIK3CG P48736 1/20 0.50
ALDH1A1 P00352 1/20 0.49
GAA P10253 1/20 0.49
PSMD14 O00487 2/20 0.48
DUSP3 P51452 1/20 0.48
PTPN5 P54829 1/20 0.48
PTPN11 Q06124 1/20 0.48
MAPT P10636 2/20 0.48
LMNA P02545 4/20 0.47
KDM1A O60341 1/20 0.47
SIRT1 Q96EB6 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14907035 0.94 GCGR (0.58) MEN1KMT2AKDM4ENPC1L3MBTL1
SCHEMBL14907122 0.89 KDM4E (0.57) MEN1KMT2AKDM4ENPC1L3MBTL1
SCHEMBL14906947 0.88 GCGR (0.54) MEN1KMT2AKDM4ENPC1L3MBTL1
SCHEMBL14906895 0.85 MEN1 (0.70) MEN1KMT2AKDM4ENPC1L3MBTL1
SCHEMBL14906938 0.85 GCGR (0.62) MEN1KMT2AKDM4ENPC1L3MBTL1
SCHEMBL12388101 0.84 KDM4E (0.70) MEN1KMT2AKDM4ENPC1L3MBTL1
SCHEMBL14906902 0.84 GCGR (0.62) MEN1KMT2AKDM4ENPC1GCGR
SCHEMBL14906950 0.83 PIK3CG (0.58) MEN1KMT2AKDM4ENPC1L3MBTL1
SCHEMBL14907022 0.81 ATM (0.57) MEN1KMT2AKDM4ENPC1L3MBTL1
SCHEMBL14906891 0.80 KDM4E (0.55) MEN1KMT2AKDM4ENPC1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9873661-B2 Small molecule malarial Aldolase-TRAP enhancers and glideosome inhibitors NEW YORK UNIVERSITY (US) 2018-01-23 US disclosed
US-20140275088-A1 SMALL MOLECULE MALARIAL ALDOLASE-TRAP ENHANCERS AND GLIDEOSOME INHIBITORS THE JOHNS HOPKINS UNIVERSITY 2014-09-18 US disclosed
WO-2013063243-A1 SMALL MOLECULE MALARIAL ALDOLASE-TRAP ENHANCERS AND GLIDEOSOME INHIBITORS NEW YORK UNIVERSITY (US) 2013-05-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140275088-A1 SMALL MOLECULE MALARIAL ALDOLASE-TRAP ENHANCERS AND GLIDEOSOME INHIBITORS ALDOA, DERA, TALDO1 MEN1 1882/4885KMT2A 929/4885KDM4E 283/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.